Search details
1.
The G-protein-coupled estrogen receptor (GPER/GPR30) in ovarian granulosa cell tumors.
Int J Mol Sci
; 15(9): 15161-72, 2014 Aug 27.
Article
in English
| MEDLINE | ID: mdl-25167139
2.
KRAS, BRAF genotyping reveals genetic heterogeneity of ovarian borderline tumors and associated implants.
BMC Cancer
; 13: 483, 2013 Oct 18.
Article
in English
| MEDLINE | ID: mdl-24139521
3.
Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer.
BMC Cancer
; 13: 616, 2013 Dec 30.
Article
in English
| MEDLINE | ID: mdl-24377825
4.
Dual-energy CT for the evaluation of silicone breast implants.
Eur Radiol
; 23(4): 991-6, 2013 Apr.
Article
in English
| MEDLINE | ID: mdl-23064715
5.
A retrospective investigation of women's experience with breast reconstruction after mastectomy.
Arch Gynecol Obstet
; 287(3): 555-61, 2013 Mar.
Article
in English
| MEDLINE | ID: mdl-23090185
6.
Treatment of breast cancer during pregnancy: an observational study.
Lancet Oncol
; 13(9): 887-96, 2012 Sep.
Article
in English
| MEDLINE | ID: mdl-22902483
7.
Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival.
BMC Cancer
; 12: 553, 2012 Nov 24.
Article
in English
| MEDLINE | ID: mdl-23176303
8.
Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer.
BMC Cancer
; 12: 2, 2012 Jan 03.
Article
in English
| MEDLINE | ID: mdl-22214378
9.
Mucin-1 and its relation to grade, stage and survival in ovarian carcinoma patients.
BMC Cancer
; 12: 600, 2012 Dec 15.
Article
in English
| MEDLINE | ID: mdl-23241107
10.
Human epididymis protein 4 (HE4) in benign and malignant diseases.
Clin Chem Lab Med
; 50(12): 2181-8, 2012 Dec.
Article
in English
| MEDLINE | ID: mdl-23093276
11.
The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses.
Clin Chem Lab Med
; 49(12): 2081-8, 2011 Sep 16.
Article
in English
| MEDLINE | ID: mdl-21923475
12.
Cetuximab monotherapy in advanced cervical cancer: a retrospective study with five patients.
Arch Gynecol Obstet
; 283(1): 109-13, 2011 Jan.
Article
in English
| MEDLINE | ID: mdl-20180130
13.
Malignant transformation within ovarian dermoid cysts: an audit of treatment received and patient outcomes. an Australia New Zealand gynaecological oncology group (ANZGOG) and gynaecologic cancer intergroup (GCIG) study.
Int J Gynecol Cancer
; 20(1): 75-81, 2010 Jan.
Article
in English
| MEDLINE | ID: mdl-20130506
14.
Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancer.
Cancer Epidemiol Biomarkers Prev
; 18(4): 1127-33, 2009 Apr.
Article
in English
| MEDLINE | ID: mdl-19336561
15.
Bortezomib treatment of ovarian cancer cells mediates endoplasmic reticulum stress, cell cycle arrest, and apoptosis.
Invest New Drugs
; 27(6): 543-51, 2009 Dec.
Article
in English
| MEDLINE | ID: mdl-19039521
16.
Breast cancer and pregnancy: challenges of chemotherapy.
Crit Rev Oncol Hematol
; 67(3): 196-203, 2008 Sep.
Article
in English
| MEDLINE | ID: mdl-18394918
17.
Nelfinavir induces TRAIL receptor upregulation in ovarian cancer cells.
Biochem Biophys Res Commun
; 377(4): 1309-14, 2008 Dec 26.
Article
in English
| MEDLINE | ID: mdl-19000651
18.
PET-CT in recurrent ovarian cancer: impact on treatment planning.
Anticancer Res
; 28(4C): 2303-8, 2008.
Article
in English
| MEDLINE | ID: mdl-18751410
19.
Phyllodes tumour of the breast: clinical follow-up of 33 cases of this rare disease.
Eur J Obstet Gynecol Reprod Biol
; 138(2): 217-21, 2008 Jun.
Article
in English
| MEDLINE | ID: mdl-17868973
20.
[Uterine leiomyomas: how to proceed]. / Uterusmyome: wann ist therapeutisches eingreifen angesagt?
MMW Fortschr Med
; 154(20): 61-3, 2012 Nov 15.
Article
in German
| MEDLINE | ID: mdl-23234123